Applying Interactive Mobile Health to Asthma Care in Teens (AIM2ACT)
AIM2ACT
mHealth Approach to Collaborative Asthma Management for Teens & Parents
2 other identifiers
interventional
92
1 country
2
Brief Summary
The aims of this application are to develop and test AIM2ACT, a mobile health (mHealth) tool, delivered via smartphones, that fosters helpful caregiver support as early adolescents (ages 12-15) with persistent asthma develop and master asthma self-management behaviors. To facilitate helpful caregiver support, AIM2ACT uses mHealth technology to determine tailored intervention targets for each family. AIM2ACT then helps caregiver/adolescent dyads set asthma management goals by automatically guiding families through a structured process that includes the supportive behavioral management strategies of goal setting, contingency management, and problem solving communication. Skills-training videos for adolescents and caregivers provide guidance on how to complete each collaborative asthma management component. AIM2ACT will be developed through feedback from an advisory board of adolescent-caregiver dyads from the target user population and a pediatric pulmonologist. Following advisory board feedback, the investigators will conduct a pilot randomized controlled trial of AIM2ACT with 50 early adolescents with poorly controlled asthma, ages 12-15 years, and a caregiver. Families will be randomly assigned to receive AIM2ACT or a self-guided condition for a 4 month intervention period. Participants in the self-guided condition will be given general information on supportive behavioral management techniques they can use to target improvement in asthma self-management behaviors. Outcomes include whether participants prefer AIM2ACT or the self-guided condition. Additionally, AIM2ACT and the self-guided condition will be compared to see if there are differences in changes in family asthma management (primary outcome), lung function, asthma control, asthma-related quality of life, and self-efficacy for asthma management. Data will be collected before participants are assigned to AIM2ACT or the self-guided control, post-treatment, and 4 month follow-up time points.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable asthma
Started Dec 2015
Typical duration for not_applicable asthma
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 24, 2014
CompletedFirst Posted
Study publicly available on registry
November 26, 2014
CompletedStudy Start
First participant enrolled
December 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 22, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 22, 2019
CompletedFebruary 18, 2021
February 1, 2021
3.2 years
November 24, 2014
February 17, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Family asthma management system scale (FAMSS) will be measured for changes in baseline, 4 months, and 8 months.
Family Asthma Management System Scale (FAMSS) a validated family clinical interview that assesses core aspects of asthma management including medication adherence, symptom assessment and response, and integration of asthma into the family system.
Change in baseline, 4 months, and 8 months.
Secondary Outcomes (5)
Spirometry will be used to measure a change in lung function at baseline, 4 months, and 8 months.
Change in baseline, 4 months, and 8 months.
Asthma control test questionnaire will be used to measure a change in symptoms at baseline, 4 months, and 8 months.
Change in baseline, 4 months, and 8 months.
Asthma-related quality of life questionnaires will be given to measure the overall quality of life changes in baseline, 4 months, and 8 months..
Change in baseline, 4 months, and 8 months.
Self-efficacy for asthma management questionnaire will be given to measure the overall improvement of the quality of life change in baseline, 4 months, and 8 months.
Change in baseline, 4 months, and 8 months.
Family communication during asthma-management tasks will be assessed via the Decision Making Involvement Scale caregiver- and adolescent-reports at baseline and 4 months.
Change in baseline and 4 months
Study Arms (2)
AIM2ACT
EXPERIMENTALAIM2ACT uses existing mHealth technology developed by the study team to elucidate tailored intervention targets for each family. AIM2ACT then facilitates collaborative caregiver/adolescent asthma management by automatically guiding dyads through a structured process that includes the supportive behavioral management strategies of goal setting, contingency management, and problem solving communication. Skills-training videos for adolescents and caregivers provide guidance on how to complete each collaborative asthma management component.
Self-Guided
ACTIVE COMPARATORParticipants in the self-guided control condition will be given general information on supportive behavioral management techniques they can use to target improvement in asthma self-management behaviors. The control condition will serve as an attention control and is designed to optimize recruitment and sustain interest while concurrently having a minimal impact on asthma management.
Interventions
AIM2ACT is a mobile health tool that is designed to facilitate collaborative asthma management between early adolescents and their caregivers.
Paper feedback and collaborative asthma management strategies are provided to early adolescents and caregivers.
Eligibility Criteria
You may qualify if:
- Lives in residence of caregiver,
- adolescent meets screening criteria for current persistent asthma,
- adolescent has uncontrolled asthma as indicated by a score of ≤ 19 on the Asthma Control Test,
- poorly controlled asthma according to National Heart, Lung, and Blood Institute (NHLBI) guidelines
- adolescent-caregiver dyad speak and read English
You may not qualify if:
- family is currently involved in an asthma management intervention, or
- adolescent has well controlled asthma as indicated by a score of ≥ 20 on the Asthma Control Test.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Floridalead
- The Miriam Hospitalcollaborator
- Rhode Island Hospitalcollaborator
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)collaborator
Study Sites (2)
University of Florida
Gainesville, Florida, 32610, United States
Benton Pediactrics
Gainesville, Florida, 32653, United States
Related Publications (2)
Fedele DA, Thomas JG, McConville A, McQuaid EL, Voorhees S, Janicke DM, Abu-Hasan M, Chi X, Gurka MJ. Using Mobile Health to Improve Asthma Self-Management in Early Adolescence: A Pilot Randomized Controlled Trial. J Adolesc Health. 2021 Dec;69(6):1032-1040. doi: 10.1016/j.jadohealth.2021.06.011. Epub 2021 Jul 15.
PMID: 34274211DERIVEDFedele DA, McConville A, Graham Thomas J, McQuaid EL, Janicke DM, Turner EM, Moon J, Abu-Hasan M. Applying Interactive Mobile health to Asthma Care in Teens (AIM2ACT): Development and design of a randomized controlled trial. Contemp Clin Trials. 2018 Jan;64:230-237. doi: 10.1016/j.cct.2017.09.007. Epub 2017 Oct 3.
PMID: 28986245DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David A Fedele, Ph.D.
University of Florida
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 24, 2014
First Posted
November 26, 2014
Study Start
December 1, 2015
Primary Completion
February 22, 2019
Study Completion
February 22, 2019
Last Updated
February 18, 2021
Record last verified: 2021-02